Is gastric cancer becoming a rare disease? A global assessment of predicted incidence trends to 2035
Centre international de recherche sur le cancer · National Cancer Institute · +4 more institutions
Abstract
The incidence of gastric cancer continues to decrease globally, approaching levels that in some populations could define it as a rare disease. To explore this on a wider scale, we predict its future burden in 34 countries with long-standing population-based data.
Plus. Numbers of new cases and age-standardised incidence rates (ASR per 100 000) were predicted up to 2035 by fitting and extrapolating age-period-cohort models.
Citation impact
- FWCI
- 44.34
- Percentile
- 100%
- References
- 45
Authors
6- MAMelina ArnoldCorresponding
Centre international de recherche sur le cancer
- JYJin Young Park
Centre international de recherche sur le cancer
- MCM. Constanza Camargo
National Cancer Institute, Division of Cancer Epidemiology and Genetics
- NLNuno Lunet
Universidade do Porto, i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto
- DFDavid Forman
University of Leeds
Topics & keywords
- Incidence (geometry)
- Demography
- Medicine
- Cancer
- Population
- Disease
- Cohort
- Internal medicine